Pfizer Inc. (PFE) Financials

PFE Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2026 204.5 billion 115.2 billion
June 30, 2026 201.1 billion 115.6 billion
March 31, 2026 207.6 billion 117.2 billion
Dec. 31, 2025 208.2 billion 121.4 billion

PFE Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2026 4.8 billion 362.0 million
June 30, 2026 302.0 million 249.0 million
March 31, 2026 2.2 billion 272.0 million
Dec. 31, 2025 4.5 billion 225.0 million

PFE Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
Sept. 30, 2026 3.2 billion
June 30, 2026 -220.0 million
March 31, 2026 2.7 billion
Dec. 31, 2025 -1.6 billion

PFE Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2026 14.3 billion 60.0 billion -
June 30, 2026 11.7 billion 60.5 billion -
March 31, 2026 13.1 billion 60.6 billion -
Dec. 31, 2025 13.6 billion 61.6 billion 2.3 billion

PFE Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2026 5.8 billion
June 30, 2026 5.7 billion
March 31, 2026 5.7 billion
Dec. 31, 2025 5.7 billion

PFE Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2026 573.0 million 3.0 billion 3.3 billion -
June 30, 2026 533.0 million 2.8 billion 3.4 billion -
March 31, 2026 436.0 million 2.5 billion 3.0 billion -
Dec. 31, 2025 845.0 million 3.2 billion 4.2 billion -

PFE Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2026 16.6 billion 4.0 billion
June 30, 2026 15.0 billion 4.1 billion
March 31, 2026 14.5 billion 3.5 billion
Dec. 31, 2025 17.6 billion 5.3 billion

PFE Revenue by Segment

Graph available only for paid members. Upgrade to see it.

PFE

Price: $27.52

52 week price:
22.41
31.05

Dividend Yield: 7.32%

5-year range yield:
3.13%
7.55%

Forward Dividend Yield: 6.25%

Payout Ratio: -365.22%

Payout Ratio Range:
-1005.23%
12122.22%

Dividend Per Share: 1.72 USD

Earnings Per Share: 0.70 USD

P/E Ratio: 41.76

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: United States

Volume: 23.8 million

Ebitda: 3.6 billion

Market Capitalization: 166.6 billion

Average Dividend Frequency: 4

Years Paying Dividends: 55

DGR3: 2.44%

DGR5: 2.50%

DGR10: 4.40%

DGR20: 5.01%

Links: